The Charlottetown meeting for the health ministers federally, provincially and territorially was interesting last week. We covered a lot of topics.

Most pointedly, one of the issues that we pressed aggressively to our federal counterparts was to make sure that one of the changes that is being recommended—that is, changing the two-year family health doctors to a three-year training—be reverted and not moved forward. Why? Because every single provincial health minister understands that it is important today, right now, to make sure that we have as many doctors going into the system as possible, and now is not the time to move from a two-year residency to a three-year. We had unanimity on that particular topic, as well as many others that I’m happy to cover in my supplementary.

I point to Trikafta, which was one of the first ones. Ontario led the Canadian jurisdictions for a new drug that treated children with cystic fibrosis. With RSV, we now have a vaccine that is Health Canada-approved and is available to our most vulnerable in Ontario, the first and only province in Canada that is doing this for long-term care and high-risk individuals in retirement homes.

Why? Because we see in Ontario a need to make sure that we protect our most vulnerable, and we act very quickly to make sure that as these drugs come online and get approved throughout Canada, they are available to Ontario citizens.